The fight against prostate cancer has entered a high-tech era, characterized by precision medicine, genomic sequencing, and artificial intelligence. As the most common cancer among men in over 100 countries, the Prostate Cancer Market is undergoing a radical shift from generalized treatments to highly personalized care pathways. The Rise of Precision Diagnostics and Theranostics One of...